Fig. 1: Potential mechanisms by which mesenchymal stem cells (MSCs) can improve outcomes in COVID-19 patients.

MSCs can directly modulate a variety of immune cells from their proinflammatory states into non-inflammatory or anti-inflammatory phenotypes, suppress cytokine storm, and promote lung regeneration.